FFAR2 and diabetic kidney disease: Gut microbiota dysbiosis leads to an increased production of acetate, which can disrupt cholesterol homeostasis and promote podocyte insulin resistance by activating GPR43, thereby causing albuminuria and renal tubular injury in rats with diabetic nephropathy (27, 28).